GLOBUS MEDICAL INC - A (GMED) Stock Institutional Trading Activity


GLOBUS MEDICAL INC - A (GMED) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q3 2025), investors with some of the largest reported share count changes include Bares Capital Management, Renaissance Technologies LLC, Sequoia Financial Advisors, and Muhlenkamp & Co. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q3 2025Bares Capital ManagementBuy521,129521,129$29,845,058
Q3 2025Sequoia Financial AdvisorsSell-1,66979,513$4,553,710
Q3 2025Renaissance Technologies LLCBuy138,500243,918$13,969,184
Q2 2025Sequoia Financial AdvisorsBuy6,11781,182$4,791,363
Q2 2025Renaissance Technologies LLCSell-71,500105,418$6,221,770
Q1 2025Sequoia Financial AdvisorsSell-18875,065$5,494,758
Q1 2025Renaissance Technologies LLCBuy18,400176,918$12,950,398
Q4 2024Sequoia Financial AdvisorsBuy3,14175,253$6,224,176
Q3 2024Sequoia Financial AdvisorsBuy15272,112$5,158,893
Q2 2024Sequoia Financial AdvisorsBuy9471,960$4,928,540
Q1 2024Sequoia Financial AdvisorsBuy771,866$3,854,893
Q4 2023Sequoia Financial AdvisorsSell-61971,859$3,829,367
Q3 2023Renaissance Technologies LLCBuy103,818158,518$7,870
Q3 2023Sequoia Financial AdvisorsBuy79772,478$3,598,533
Q2 2023Sequoia Financial AdvisorsBuy71,68171,681$4,267,887
Q2 2022Renaissance Technologies LLCSell-10,10054,700$3,071
Q1 2022Renaissance Technologies LLCBuy17,70064,800$4,781
Q4 2021Renaissance Technologies LLCSell-133,54647,100$3,401
Q3 2021Renaissance Technologies LLCBuy37,546180,646$13,841
Q2 2021Renaissance Technologies LLCSell-25,600143,100$11,095
Q1 2021Renaissance Technologies LLCBuy39,200168,700$10,404
Q4 2020Renaissance Technologies LLCSell-14,014129,500$8,446
Q3 2020Renaissance Technologies LLCSell-566,800143,514$7,107
Q2 2020Renaissance Technologies LLCSell-634,400710,314$33,889
Q1 2020Renaissance Technologies LLCBuy266,7001,344,714$57,191
Q4 2019Renaissance Technologies LLCSell-167,3861,078,014$63,473
Q3 2019Renaissance Technologies LLCSell-19,2001,245,400$63,665
Q2 2019Renaissance Technologies LLCSell-95,2001,264,600$53,493
Q1 2019Renaissance Technologies LLCBuy137,4001,359,800$67,188
Q4 2018Renaissance Technologies LLCBuy331,9651,222,400$52,905

Frequently asked questions about GMED activity

  • Which institutional owners are buying GMED?

    Institutional owners buying GMED include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in GMED activity?

    "Buy" means an investor increased their reported position in GMED compared to the prior reporting period. This reflects growing exposure to GLOBUS MEDICAL INC - A (GMED) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in GMED increasing?

    Institutional interest in GMED can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.